Webster E A, Khakoo A Y, Mackus W J, Karpusas M, Thomas D W, Davidson A, Christian C L, Lederman S
Columbia University, New York, New York 10032, USA.
Arthritis Rheum. 1999 Jun;42(6):1291-6. doi: 10.1002/1529-0131(199906)42:6<1291::AID-ANR29>3.0.CO;2-#.
Hyper-IgM syndrome (HIM) is a rare immunodeficiency disorder that has been associated with the development of symptoms and clinical features characteristic of rheumatoid arthritis (RA). We describe a patient with HIM and severe erosive arthritis with prominent nodules in the absence of detectable serum rheumatoid factor. Because HIM results from defects in either T cell CD154 (CD40 ligand) expression or abnormal CD40 signaling, the molecular basis of the patient's disease was analyzed. Activated CD4+ T cells failed to express surface CD154 protein, and molecular analysis of CD154 complementary DNA revealed a nucleotide transversion resulting in the nonconservative amino acid substitution G-D at amino acid 257. This case indicates that defective CD154-dependent CD40 signaling can be associated with susceptibility to a severe inflammatory arthritis that has both similarities to and differences from idiopathic RA.